Multiple carboxylase deficiency, biotin responsive
```
Multiple Carboxylase Deficiency, Biotin Responsive |
---|
Multiple Carboxylase Deficiency, Biotin Responsive is a rare metabolic disorder characterized by the body's inability to properly process certain carboxylase enzymes due to a deficiency in biotin. Biotin, also known as vitamin B7, is a crucial coenzyme for carboxylase enzymes involved in processes such as fatty acid synthesis, amino acid catabolism, and gluconeogenesis. This disorder is categorized into two main types: early-onset, known as Holocarboxylase Synthetase Deficiency, and late-onset, known as Biotinidase Deficiency.
Symptoms and Signs[edit | edit source]
Symptoms of Multiple Carboxylase Deficiency can vary widely but often include skin rash, alopecia (hair loss), seizures, ataxia (lack of muscle coordination), developmental delay, and metabolic acidosis. The severity and onset of symptoms depend on the type of deficiency (early or late onset).
Causes[edit | edit source]
The disorder is caused by mutations in genes responsible for the activation (in the case of Holocarboxylase Synthetase Deficiency) or recycling (in the case of Biotinidase Deficiency) of biotin. These mutations lead to reduced activity of biotin-dependent carboxylase enzymes.
Diagnosis[edit | edit source]
Diagnosis of Multiple Carboxylase Deficiency involves clinical evaluation of symptoms, biochemical tests showing abnormal levels of organic acids in the urine, and genetic testing to identify mutations in the relevant genes.
Treatment[edit | edit source]
The primary treatment for Multiple Carboxylase Deficiency is the administration of oral biotin supplements. This treatment is often effective in reversing symptoms and preventing complications if started early. The dosage and duration of biotin therapy may vary depending on the type of deficiency and the severity of symptoms.
Prognosis[edit | edit source]
With early diagnosis and appropriate treatment, individuals with Multiple Carboxylase Deficiency can lead normal, healthy lives. However, delayed treatment or lack of treatment can result in serious complications, including developmental delays and life-threatening metabolic crises.
Resources[edit source]
Latest articles - Multiple carboxylase deficiency, biotin responsive
Source: Data courtesy of the U.S. National Library of Medicine. Since the data might have changed, please query MeSH on Multiple carboxylase deficiency, biotin responsive for any updates.
```
This source code formatted article provides a comprehensive overview of Multiple Carboxylase Deficiency, Biotin Responsive, including its symptoms, causes, diagnosis, treatment, and prognosis. It includes internal links to related articles and categories to facilitate navigation within the encyclopedia. The stub template at the end indicates that the article is a start and could be expanded with more detailed information.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD